Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Acceptys Inc.

Latest From Acceptys Inc.

Acceptys Inc.

With an engineered cell line, Acceptys can capture, screen and produce naturally occurring human antibodies ex vivo.
BioPharmaceutical Research and Development Strategies

Therapeutic Antibody Start-Ups

After more than a decade of anticipation, pharmas have now clearly recognized the value of antibodies as therapeutics. And biotechs can offer discovery tools and development expertise.
BioPharmaceutical Research and Development Strategies

Start-Up Previews (12/03)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Therapeutic Antibodies, features profiles of Acceptys Inc., KaloBios Inc. and Rinat Neuroscience Corp. Plus these Start-Ups Across Health Care: Atritech Inc, AusAm Biotechnologies Inc., Cenix BioScience GMBH and TransOral Pharmaceuticals Inc.
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Acceptys Inc.
  • Senior Management
  • Daniel Devine, Pres. & CEO
    Stephen Ginsberg, VP, Fin. & Admin.
    Tony Giordano, PhD, CSO
    James B Singleton, Dir., Bus. Dev.
  • Contact Info
  • Acceptys Inc.
    Phone: (212) 795-7790
    Audubon Technology Park
    3960 Broadway
    New York, NY 10032